Obermatt
See Similar Stocks →

Samjin Pharmaceutical

KSC:005500 · KR7005500004
PharmaceuticalsSmall

360° View

87
Price/Sales69
Price/Earnings54
Price/Book57
Dividend Yield1
Revenue Growth84
Profit Growth43
Capital Growth100
TSR 52w81
Leverage48
Liquidity68
Refinancing78
Combined94
Analyst Opinions100
Pro Holdings22
Opinion Changes50
Market Pulse39

Profile

CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeKOSE
Employees26
Websitesamjinpharm.co.kr
ISINKR7005500004
Last UpdateApr 2, 2026
Index & Theme
Chronic DiseasesPain ManagementOphthalmologyDiabetesNeurologyOncologyCentral Nervous SystemBiotechnologyPharmaceutical

Description

Analysis

Samjin Pharmaceutical's 360° View rank of 87 places it among the strongest overall — better than 87% of its true peers.

It's a growth standout (93) and reasonably valued (54). On safety it is very well financed (77), and the market shows favorable sentiment (54). Taken together, its Combined rank of 94 reads as among the strongest overall.

360° rank · history

1007550250
87
2026

All-time high

91

Mar 2026

All-time low

87

Jun 2026

Average rank

89

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
69
—
—
—
Price/Earnings
54
—
—
—
Price/Book
57
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
54
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Samjin Pharmaceutical with its peers
Ilsung IS
KSC:003120
59
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Lotus Pharmaceutical
TAI:1795
19
CountryTaiwan
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Mayne Pharma
ASX:MYX
55
CountryAustralia
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Hanmi Pharmaceutical
KSC:128940
76
CountrySouth Korea
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Towa Pharmaceutical
TYO:4553
50
CountryJapan
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →
Pyridam Farma
JKT:PYFA
3
CountrySingapore
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →